T1	intervention 0 31	Ovarian ablation or suppression
T2	eligibility 551 702	pre- and perimenopausal patients with early-stage breast cancer who were receiving prolonged (5 years) tamoxifen treatment with or without chemotherapy
T3	control 849 883	no ovarian ablation or suppression
T6	total-participants 1060 1064	2144
T7	intervention-participants 1066 1070	1063
T8	control-participants 1104 1108	1081
T9	intervention-participants 1189 1192	942
T10	outcome 1341 1362	relapse-free survival
T11	iv-bin-abs 1454 1457	290
T12	cv-bin-abs 1472 1475	306
T15	outcome 1552 1568	overall survival
T16	iv-bin-abs 1676 1679	215
T17	cv-bin-abs 1694 1697	230
T5	outcome 1922 1943	relapse-free survival
T13	outcome 1947 1963	overall survival
T4	outcome-Measure 910 922	relapse-free
T14	outcome-Measure 927 943	overall survival
